{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:47:46Z","timestamp":1775735266931,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11A5621N and 11A5623N"],"award-info":[{"award-number":["11A5621N and 11A5623N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CSL-Behring"},{"name":"Abacus research grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41971-9","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T13:03:45Z","timestamp":1772543025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multiplex allele-specific polymerase chain reaction assay for rapid and affordable detection of APOL1 risk variants"],"prefix":"10.1038","volume":"16","author":[{"given":"Oyindamola Christiana","family":"Adebayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Bongaers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Levtchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambertus","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"Labarque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"41971_CR1","doi-asserted-by":"crossref","unstructured":"Saran, R. et al. US Renal Data System 2016 annual data report: Epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 69, A7\u2013A8 (2017).","DOI":"10.1053\/j.ajkd.2017.01.036"},{"key":"41971_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0272-6386(12)80806-7","volume":"23","author":"C Byrne","year":"1994","unstructured":"Byrne, C., Nedelman, J. & Luke, R. G. Race, socioeconomic status, and the development of end-stage renal disease. Am. J. Kidney Dis. 23, 16\u201322 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"41971_CR3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1056\/NEJM198205273062106","volume":"306","author":"SG Rostand","year":"1982","unstructured":"Rostand, S. G., Kirk, K. A., Rutsky, E. A. & Pate, B. A. Racial differences in the incidence of treatment for end-stage renal disease. N. Engl. J. Med. 306, 1276\u20131279 (1982).","journal-title":"N. Engl. J. Med."},{"key":"41971_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese, G. et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841\u2013845 (2010).","journal-title":"Science"},{"key":"41971_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","volume":"128","author":"S Tzur","year":"2010","unstructured":"Tzur, S. et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum. Genet. 128, 345\u2013350 (2010).","journal-title":"Hum. Genet."},{"key":"41971_CR6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1073\/pnas.1522913113","volume":"113","author":"OA Olabisi","year":"2016","unstructured":"Olabisi, O. A. et al. APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases. Proc. Natl. Acad. Sci. U. S. A. 113, 830\u2013837 (2016).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"41971_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00467-020-04553-z","volume":"36","author":"PM Ekulu","year":"2021","unstructured":"Ekulu, P. M. et al. A focus on the association of Apol1 with kidney disease in children. Pediatr. Nephrol. 36, 777\u2013788 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"41971_CR8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","volume":"22","author":"JB Kopp","year":"2011","unstructured":"Kopp, J. B. et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 22, 2129\u20132137 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"41971_CR9","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1681\/ASN.2014050469","volume":"26","author":"AN Kasembeli","year":"2015","unstructured":"Kasembeli, A. N. et al. APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans. J. Am. Soc. Nephrol. 26, 2882\u20132890 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"41971_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ekir.2019.04.002","volume":"4","author":"PM Ekulu","year":"2019","unstructured":"Ekulu, P. M. et al. APOL1 risk genotypes are associated with early kidney damage in children in sub-Saharan Africa. Kidney Int. Rep. 4, 930\u2013938 (2019).","journal-title":"Kidney Int. Rep."},{"key":"41971_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/bjh.17832","volume":"196","author":"OC Adebayo","year":"2022","unstructured":"Adebayo, O. C. et al. Clinical and genetic factors are associated with kidney complications in African children with sickle cell anaemia. Br. J. Haematol. 196, 204\u2013214 (2022).","journal-title":"Br. J. Haematol."},{"key":"41971_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3324\/haematol.2015.124875","volume":"100","author":"SL Saraf","year":"2015","unstructured":"Saraf, S. L. et al. Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy. Haematologica 100, 1275\u20131284 (2015).","journal-title":"Haematologica"},{"key":"41971_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","volume":"155","author":"AE Ashley-Koch","year":"2011","unstructured":"Ashley-Koch, A. E. et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br. J. Haematol. 155, 386\u2013394 (2011).","journal-title":"Br. J. Haematol."},{"key":"41971_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/art.38220","volume":"66","author":"BI Freedman","year":"2014","unstructured":"Freedman, B. I. et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 66, 390\u2013396 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"41971_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jmoldx.2015.11.003","volume":"18","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Analytical validation of a personalized medicine APOL1 genotyping assay for nondiabetic chronic kidney disease risk assessment. J. Mol. Diagn. 18, 260\u2013266 (2016).","journal-title":"J. Mol. Diagn."},{"key":"41971_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1746-4811-8-34","volume":"8","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. An improved allele-specific PCR primer design method for SNP marker analysis and its application. Plant. Methods. 8, 34 (2012).","journal-title":"Plant. Methods"},{"key":"41971_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12882-025-04687-y","volume":"27","author":"OC Adebayo","year":"2025","unstructured":"Adebayo, O. C. et al. APOL1-mediated kidney disease: a narrative review of the lessons learnt from the past 15 years. BMC Nephrol. 27, 60 (2025).","journal-title":"BMC Nephrol."},{"key":"41971_CR18","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1038\/s44321-024-00126-x","volume":"16","author":"R Greensmith","year":"2024","unstructured":"Greensmith, R. et al. CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment. EMBO Mol. Med. 16, 2619\u20132637 (2024).","journal-title":"EMBO Mol. Med."},{"key":"41971_CR19","doi-asserted-by":"crossref","unstructured":"Haun, R. S., Larsen, C. P., Wilson, J. D. & Kenan, D. J. High-fidelity CRISPR-Cas12a-based apolipoprotein L1 genotyping. Kidney360 6, 1207\u20131217 (2025).","DOI":"10.34067\/KID.0000000871"},{"key":"41971_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2710.2007.00822.x","volume":"32","author":"LK Teh","year":"2007","unstructured":"Teh, L. K., Lee, W. L., Amir, J., Salleh, M. Z. & Ismail, R. Single step PCR for detection of allelic variation of MDR1 gene (P-glycoprotein) among three ethnic groups in Malaysia. J. Clin. Pharm. Ther. 32, 313\u2013319 (2007).","journal-title":"J. Clin. Pharm. Ther."},{"key":"41971_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1365-2141.1998.00535.x","volume":"100","author":"SL Pearson","year":"1998","unstructured":"Pearson, S. L. & Hessner, M. J. A 1,2BO1,2 genotyping by multiplexed allele-specific PCR. Br. J. Haematol. 100, 229\u2013234 (1998).","journal-title":"Br. J. Haematol."},{"key":"41971_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2350-14-27","volume":"14","author":"MN Darawi","year":"2013","unstructured":"Darawi, M. N. et al. Allele-specific polymerase chain reaction for the detection of Alzheimer\u2019s disease-related single nucleotide polymorphisms. BMC Med. Genet. 14, 27 (2013).","journal-title":"BMC Med. Genet."},{"key":"41971_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1099\/jmm.0.47534-0","volume":"57","author":"BR Sapkota","year":"2008","unstructured":"Sapkota, B. R., Ranjit, C., Neupane, K. D. & Macdonald, M. Development and evaluation of a novel multiple-primer PCR amplification refractory mutation system for the rapid detection of mutations conferring rifampicin resistance in codon 425 of the rpoB gene of Mycobacterium leprae. J. Med. Microbiol. 57, 179\u2013184 (2008).","journal-title":"J. Med. Microbiol."},{"key":"41971_CR24","first-page":"43","volume":"5","author":"PY Kwok","year":"2003","unstructured":"Kwok, P. Y. & Chen, X. Detection of single nucleotide polymorphisms. Curr. Issues Mol. Biol. 5, 43\u201360 (2003).","journal-title":"Curr. Issues Mol. Biol."},{"key":"41971_CR25","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/nar\/17.7.2503","volume":"17","author":"CR Newton","year":"1989","unstructured":"Newton, C. R. et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17, 2503\u20132516 (1989).","journal-title":"Nucleic Acids Res."},{"key":"41971_CR26","doi-asserted-by":"publisher","first-page":"995","DOI":"10.4314\/ahs.v18i4.20","volume":"18","author":"ET Toye","year":"2018","unstructured":"Toye, E. T., van Marle, G., Hutchins, W., Abgabiaje, O. & Okpuzor, J. Single tube allele specific PCR: a low cost technique for molecular screening of sickle cell anaemia in Nigeria. Afr. Health Sci. 18, 995\u20131002 (2018).","journal-title":"Afr. Health Sci."},{"key":"41971_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2215\/CJN.15161219","volume":"16","author":"DJ Friedman","year":"2021","unstructured":"Friedman, D. J. & Pollak, M. R. APOL1 nephropathy: From genetics to clinical applications. Clin. J. Am. Soc. Nephrol. 16, 294\u2013303 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"41971_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","volume":"21","author":"S Limou","year":"2014","unstructured":"Limou, S., Nelson, G. W., Kopp, J. B. & Winkler, C. A. APOL1 kidney risk alleles: Population genetics and disease associations. Adv. Chronic Kidney Dis. 21, 426\u2013433 (2014).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"41971_CR29","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1097\/TP.0000000000003641","volume":"105","author":"MD Doshi","year":"2021","unstructured":"Doshi, M. D. et al. Integrating APOL1 kidney-risk variant testing in live kidney donor evaluation: An expert panel opinion. Transplantation 105, 2132\u20132134 (2021).","journal-title":"Transplantation"},{"key":"41971_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jcla.20454","volume":"25","author":"S Ataei","year":"2011","unstructured":"Ataei, S., Nateghpour, M., Hajjaran, H., Edrissian, G. H. & Foroushani, A. R. High specificity of semi-nested multiplex PCR using dried blood spots on DNA Banking Card in comparison with frozen liquid blood for detection of Plasmodium falciparum and Plasmodium vivax. J. Clin. Lab. Anal. 25, 185\u2013190 (2011).","journal-title":"J. Clin. Lab. Anal."},{"key":"41971_CR31","unstructured":"Ojo, A. O. et al. APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. (2025)."},{"key":"41971_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1681\/ASN.2016040441","volume":"28","author":"K Shukha","year":"2017","unstructured":"Shukha, K. et al. Most ApoL1 is secreted by the liver. J. Am. Soc. Nephrol. 28, 1079\u20131083 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"41971_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/bjh.14842","volume":"179","author":"R Kormann","year":"2017","unstructured":"Kormann, R. et al. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target. Br. J. Haematol. 179, 323\u2013335 (2017).","journal-title":"Br. J. Haematol."},{"key":"41971_CR34","doi-asserted-by":"crossref","unstructured":"Nkoy, A. B. et al. Relevance of repeated analyses of albuminuria and glomerular filtration rate in African children with sickle cell anaemia. Br. J. Haematol (2024).","DOI":"10.1111\/bjh.19603"},{"key":"41971_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/bjh.14724","volume":"178","author":"A Geard","year":"2017","unstructured":"Geard, A. et al. Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon. Br. J. Haematol. 178, 629\u2013639 (2017).","journal-title":"Br. J. Haematol."},{"key":"41971_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00467-021-05126-4","volume":"37","author":"OC Adebayo","year":"2022","unstructured":"Adebayo, O. C., Van den Heuvel, L. P., Olowu, W. A., Levtchenko, E. N. & Labarque, V. Sickle cell nephropathy: insights into the pediatric population. Pediatr. Nephrol. 37, 1231\u20131243 (2022).","journal-title":"Pediatr. Nephrol."},{"key":"41971_CR37","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00467-010-1736-2","volume":"26","author":"AM Becker","year":"2011","unstructured":"Becker, A. M. Sickle cell nephropathy: Challenging the conventional wisdom. Pediatr. Nephrol. 26, 2099\u20132109 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"41971_CR38","first-page":"1","volume":"197","author":"RB Baptista","year":"2019","unstructured":"Baptista, R. B. & Almeida, E. The emerging challenge of sickle cell nephropathy. Nephrol. Dial Transpl. 197, 1\u20133 (2019).","journal-title":"Nephrol. Dial Transpl."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41971-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41971-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41971-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:55:25Z","timestamp":1775732125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41971-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41971"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41971-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11860"}}